💊 Hear from #iDR25 speakers, Christophe Lahorte and Yorick Peterse, how iDR brings together funders, regulators, patients, scientists and more to develop a better regulatory framework for drug repurposing. Join us in Brussels on 12-13 May ➡️ Discover more: www.remedi4all.org/iDR26

📣 New Medicines Reimagined Story - Obinutuzumab: From Cancer to Lupus. Each month, we showcase how how new uses have been found for existing medicines through #DrugRepurposing ➡️ Read more about how this innovation was brought to life here: https://loom.ly/4Qp4-yg

⏰ Last chance to apply for a lightning talk at #iDR26 ⏰ Applications close tonight! 🗓 Proposal submission deadline: 27 February 2026 🔗 Learn more and submit your proposal: https://loom.ly/XvNoRTM

Every Friday in February, REMEDi4ALL shared a unique case of drug repurposing for rare diseases to mark #RareDiseaseDay 2026 for the 300 million people worldwide who live with a rare disease.  🔗 Read more here: https://loom.ly/EnqcwX0

📣 Announcing the first lineup of speakers for #iDR26! From new approaches to drive repurposing research in rare diseases to creating ecosystems to drive patient impact, these speakers will share their expertise on drug repurposing. 🔗 Learn more and register today: https://loom.ly/9dw7qdk

💻 #REMEDi4ALL Funders Network Webinar: Working with Regulators: Pre-grant scientific advice Funders & regulators discuss why pre‑grant regulatory scientific advice (PGRSA) matters for #DrugRepurposing, with real case studies + insights from IncreaseNET. 🔗 Materials: https://loom.ly/ZTiu4mQ#REMEDi4ALL

🔦Have you had a chance to explore the #iDR26 at‑a‑glance programme? Patients, researchers, industry, funders & policy-makers are coming together to drive drug repurposing forward. Join us to deliver real patient impact! Explore the full programme and secure your ticket➡️ https://loom.ly/YsrB-jM

🧬 To mark #RareDiseaseDay, we're sharing case studies on drug repurposing for rare diseases every Friday in February. 👉 Read more about Alkaptonuria and Nitisinone here: https://loom.ly/jbuP2O4

🧭💊 Introducing our first iDR26 track: Drug Repurposing for Rare Diseases! 🛣️ When is repurposing the right path for rare diseases? Join us to explore when it works, why it’s chosen, and who benefits. 🎧 Hear from track lead Beacon below 🎟️ Tickets: https://loom.ly/RA5Yss4

⏰ One week left to apply for a lightning talk at #iDR26 ⏰ Have an idea, project, or insight in drug repurposing you’d like to spotlight? Submit a proposal for a lightning talk today! 🗓 Proposal submission deadline: 27 February 2026 🔗 Learn more and submit your proposal: https://loom.ly/XvNoRTM#iDR26

💡 Did you know? Your go‑to resource for drug repurposing training is already live! Offering on‑demand learning, hands‑on bootcamps, hackathons and ongoing webinars to support the drug repurposing community. Explore all REMEDi4ALL training opportunities➡️https://loom.ly/thCPXrc

🧬 To mark #RareDiseaseDay, we're sharing case studies on drug repurposing for rare diseases every Friday in February. This time, we highlight the drug Guanabenz repurposed to treat Vanishing White Matter. 👉 Read more about Guanabenz and Vanishing White Matter here: https://loom.ly/KPXaduY

💊 Collaboration is key to unlocking the full potential of drug repurposing. Through #iDR26 and global partnerships, REMEDi4ALL is creating spaces to connect, collaborate and accelerate progress. Join us in Brussels to learn more ➡️ www.remedi4all.org/iDR266

📣 Annika Jenmalm Jensen, Infrastructure Director at @scilifelab.se, shares why #iDR26 is a key event in the international drug repurposing community. Join us on 12 & 13 May in Brussels. 👉 Learn more and register here: https://loom.ly/9dw7qdk

#iDR26 is for patients and patient organisations! Contribute to discussions shaping the future of access and development. Register now and apply for a lightning talk before 27 February: https://loom.ly/XvNoRTM 💜 Find out more about our patient bursaries here: https://loom.ly/Ff53lz0

At #iDR, the patient voice is at the heart of the programme. 🎬 Hear from patient advocates on the impact of the #iDR conference and why patient perspectives are essential in drug repurposing. Patient groups: join us at #iDR26 ➡️ discounted tickets here https://loom.ly/ToR-dtw

Join the 'Medicines Reimagined' Forum, where enthusiasts and experts in drug repurposing unite! Connect, collaborate, share insights, and explore the challenges and successes in the #DrugRepurposing field. 👉 Join the dialogue today: https://remedi4all.org/stakeholder-forum

Submit a proposal for a lightning talk before 27 February 🎤 When you register for #iDR26, don’t miss the chance to share your story on stage. Have an idea, project, or insight in drug repurposing you’d like to spotlight? 🔗 Register here: https://loom.ly/XvNoRTM

⏰LAST CHANCE ⏰ #iDR26 early bird tickets close tomorrow! Join the leading international conference on drug repurposing and engage with global experts shaping the future of patient-centric medicines. 🎟️ Get your early bird ticket here: https://loom.ly/9dw7qdk

📣 Learn from the diverse strategies and approaches in #DrugRepurposing at #iDR26! Join us to connect, share knowledge, and navigate the future of medicines repurposing. 🔗 Learn more and register for an early bird ticket by 31 Jan here: https://loom.ly/9dw7qdk

🆕Updated: REMEDi4ALL guide to creating joint calls for impactful drug repurposing research Joint calls enable cross-border projects, increase available funding, and combine funder expertise for greater impact. Explore the latest updates to the guide➡️ https://loom.ly/CCPshvs

⏰ LAST CALL! Only 1 week left to secure early bird tickets for #iDR26. Join the international drug repurposing conference & explore the future of patient-centric medicines- from rare diseases and AI-driven discovery to policy, funding, and community-led success stories. 👉 https://loom.ly/9dw7qdk

⏰It’s official: the #iDR26 at-a-glance programme has landed! From rare diseases and AI-driven discovery to policy, funding and community-led success stories, iDR26 brings key stakeholders together for real patient impact. 🎟️Early bird tickets available until 31 Jan➡️https://remedi4all.org/iDR26

🔍 Did you know REMEDi4ALL has developed practical resources to support in-silico drug repurposing research? From a DR catalogue and expert publications to SOPs and an expertise dashboard, these tools help scientists work efficiently and collaboratively. Explore resources➡️https://loom.ly/Ne32Kbk

🌐New REMEDi4ALL Funders Network members: 14 new members have joined the REMEDi4ALL Funders Network this year! 🤝The network brings global funders together to collaborate, share best practices & support drug repurposing research. Find out more about joining ➡️ https://loom.ly/YgguS8E

⏰REMEDi4ALL Academic Bootcamp deadline extended - limited places still remain!⏰ Join the REMEDi4ALL Academic Bootcamp (11–12 Mar 2026, Cambridge, UK) for hands-on drug repurposing training. Fully funded for selected participants. 📅 Apply now ➡️ https://loom.ly/4QEaVoc

🚨 Today is the deadline to submit your abstract for the #iDR26 Poster Session! Showcase your work, stories, and experiences to an international audience of professionals and thought leaders in the drug repurposing field! 👉 Learn more and submit your abstract here: https://loom.ly/XvNoRTM

Bursaries available for patients and patient representatives at #iDR26! In order to facilitate meaningful patient participation at iDR26, participants may be granted financial support to cover travel, accommodation, and ticketing. 👉 Learn more about patient bursaries here: https://loom.ly/Ff53lz0

💊 Could an existing medicine offer new options for people living with Osteogenesis Imperfecta, and could you take part? The REMEDi4ALL MOI-A study is recruiting patients across Europe to explore whether repurposing losartan could benefit people living with OI. 📽️ More: https://loom.ly/HT__zsw

⏰ REMEDi4ALL Academic Bootcamp: applications close tomorrow! This is your last chance to apply for the REMEDi4ALL Academic Bootcamp (11–12 March 2026, Cambridge, UK) and take your drug repurposing idea to the next stage with expert support. 🗓️Deadline: 14 January 🔗Apply: https://loom.ly/4QEaVoc

⏳ 1 week to go until applications close! Don’t miss your chance to join the REMEDi4ALL Academic Bootcamp (11–12 March 2026, Cambridge, UK) and take your drug repurposing idea to the next stage with expert support. 🗓️ Applications close 14 Jan 🔗 Register now: https://loom.ly/4QEaVoc

🧭 Join the global drug repurposing community at #iDR26 and contribute your work or perspective. You can take part by submitting an abstract for the Poster Session or by applying for a Lightning Talk. Read more and find the deadlines below! ➡️ Apply here: https://loom.ly/XvNoRTM

💊Interested in taking your drug repurposing idea to the next level? 🔬 Join the REMEDi4ALL Academic Bootcamp on 11–12 March 2026 in Cambridge, UK: a hands-on programme to help researchers advance promising repurposing concepts. ⌛ Apply by 14 Jan: https://loom.ly/4QEaVoc

📚New from REMEDi4ALL demonstrator project: Can an existing blood pressure medicine improve bone health in osteogenesis imperfecta? A phase II trial is repurposing losartan to target overactive TGFβ signalling in adolescents & adults with OI. 🔗 https://loom.ly/Eb_ueT0 #DrugRepurposing

❄️ Season’s greetings from #REMEDi4ALL! We are grateful for your support in advancing drug repurposing and look forward to continued impact in the year ahead.

Bursaries are available for patients and patient representatives to attend iDR26! Meaningful patient participation is a core element of iDR26. Below, patients and patient organisations share their experiences of attending last year’s conference. 👉 More information here: https://loom.ly/Ff53lz0

🚨Breaking! #iDR26 is excited to announce our four conference tracks for this year🚨 🌐Rare Diseases 🔍Discovery 💼Industry 👥Community Interested in learning more about these key areas in drug repurposing? Join us on 12-13 May in Brussels (limited early bird tickets)➡️ https://loom.ly/9dw7qdk

Prof. Irena Mlinarič Raščan of the University of Ljubljana, a REMEDi4ALL partner, was recently featured in DELO, Slovenia’s largest daily newspaper, in an in-depth article exploring the future of drug repurposing and her work with #REMEDi4ALL. 🔗 Read the article here: https://loom.ly/9kv7-MY

🔍New open-access REMEDi4ALL resource for in silico drug repurposing! Two annotation workflows (KNIME + Python/Neo4j) help extract, harmonise & explore chemical and bioactivity data across >5000 compounds for drug repurposing! 🔗Read the open access article in Database➡️ https://loom.ly/nboSzbk

📚 A new study from REMEDi4ALL partner University of Ljubljana introduces a human cell–based laboratory model to improve understanding of cytokine storm: overreaction of the immune system in severe infections. Read the full article here➡️ https://loom.ly/nYdimM0

Get involved in the global drug repurposing community at #iDR26 and don’t miss your chance to contribute! Hear from last year's participants below! 🔬 Poster Session – Deadline: 10 January 2026 ⚡ Lightning Talks - Deadline: 27 February 2026 Submit your application here: https://loom.ly/XvNoRTM#iDR26

🎓 Applications are open for the REMEDi4ALL Drug Repurposing Bootcamp! A hands-on programme with expert guidance to help researchers take repurposing ideas toward real patient impact. Funding is provided for selected participants. 📝 Apply by 14 Jan here: https://loom.ly/4QEaVoc

📣 New Medicines Reimagined story! Nitisinone went from an herbicide to an approved treatment for two rare diseases (HT-1 & AKU). A remarkable example of #DrugRepurposing powered by science and patient advocacy. ➡️ https://loom.ly/4Qp4-yg

Help shape the future of drug repurposing at #iDR26 🧭 Join a diverse community of stakeholders, collaborating to strengthen the drug repurposing ecosystem and navigate the future of cutting-edge science to maximise patient benefit. 🔗 More details: https://loom.ly/ToR-dtw

Last week, REMEDi4ALL spoke to the TAR Network, joining 27 participants to discuss how resources can support repurposing initiatives. ☑️Highlights: concierge support, funding marketplace, value assessment tool, webinars, and policy/patient engagement. 👥More collaboration ahead!

🎓Join us for the REMEDi4ALL Academic Bootcamp 2026! Following a highly successful inaugural edition, applications are now open for the 2026 REMEDi4ALL Academic Bootcamp at Wellcome Genome Campus (Cambridge, UK)! 🗓️Dates: 11–12 March 2026 ➡️Apply here by 14 Jan: https://loom.ly/4QEaVoc

🗞️Breaking news: REMEDi4ALL is supporting an important effort to advance treatment options for children with KCNQ2-Developmental and Epileptic Encephalopathy, a rare early-onset epilepsy with limited treatment options. More➡️ https://loom.ly/J3ocQH4

🟣 Over the next few days, REMEDi4ALL partner Medicines for Europe will highlight how value added medicines (VAMs) are transforming access by rethinking, reinventing and optimising existing medicines. Follow #VAMWeek 2025 to find out more!

If you’re a patient or part of a patient group, #iDR26 offers a chance to: 🔹 Share your experiences and perspectives in discussions shaping the future of drug repurposing 🔹 Hear directly from researchers, clinicians and regulators Register for iDR26 here: https://loom.ly/Qo4ko8s

🎬 Inside the 2025 REMEDi4ALL Hackathon! Early career researchers from across Europe gathered near Montserrat to tackle real-world challenges in drug repurposing for rare neurodevelopmental disorders. Catch the highlights ➡️https://loom.ly/N6tXCHs